chevron-down Created with Sketch Beta.

Antitrust Law Journal

Volume 83, Issue 1

Maximum Resale Price Maintenance and Retailer Cartel Profits: Evidence from the Indian Pharmaceutical Industry

Ajay Bhaskarabhatla

Summary

  • In jurisdictions where maximum resale price maintenance (MRPM) is per se legal, manufacturers can compete for a retailer cartel’s patronage by selectively increasing the maximum resale price consumers pay but not the price the retailer cartel pays.
  • The retailer cartel can effectively collude on maximum resale price, which serves as a focal point, allocate market shares among manufacturers based on the retail margins they receive, and, as a punishment, boycott manufacturers offering low margins. In such a setup, MRPM raises retailer profits and undermines consumer welfare by promoting the growth of manufacturers with relatively higher margins.
  • Using data on the pricing of pharmaceuticals in India, we test these predictions and find consistent evidence. Overall, our results indicate that vertical price restraints such as MRPM, although considered welfare enhancing and per se not illegal under US jurisprudence, can sometimes facilitate horizontal collusion among manufacturers and/or retailers.
Maximum Resale Price Maintenance and Retailer Cartel Profits: Evidence from the Indian Pharmaceutical Industry
DanielPrudek via Getty Images

Jump to:

Resale price maintenance (RPM), a vertical agreement between a manufacturer and a retailer that specifies a fixed minimum or maximum resale price, can be procompetitive. Minimum RPM can help a manufacturer maintain retail service quality and enhance brand reputation. Maximum RPM can limit retailer market power and improve the efficiency of franchising. Therefore, in the United States, the per se illegality of maximum RPM ended in 1997 after State Oil Company v. Khan, and that of minimum RPM ended in 2007 after Leegin v. PSKS. RPM is not per se legal in the United States, but it remains subject to a rule-of-reason analysis. Our thinking about RPM is shaped largely by the economic and legal analyses set in the United States. Examining jurisdictions featuring relatively friendlier legal treatment towards RPM can be instructive in revealing potential anticompetitive effects.

In this article, I examine how India’s treatment of maximum RPM (MRPM) as per se legal, and its violation as illegal, facilitates cartelization. Ample anecdotal evidence indicates that MRPM, introduced in India in 1990 for packaged goods to provide greater transparency in consumer prices, can facilitate collusion. Although the maximum resale price (MRP) is not necessarily the final selling price, “retailers do not compete, and MRP becomes the reference price for them to collude informally.”

Economic theory suggests that non-binding price ceilings like MRPM serve as focal points for tacit collusion. Also, in theory, prices under a system of RPM are more uniform, deviations from cartel agreements are easier to detect, collusion is easier to sustain even when wholesale prices are difficult to observe, and retailer profits are larger as retail services are allocated toward the high-priced products, excluding rivals. The Court’s opinion in Leegin echoes these theoretical concerns: “A manufacturer with market power, by comparison, might use resale price maintenance to give retailers an incentive not to sell the products of smaller rivals or new entrants.”

In this article, I suggest that in jurisdictions where MRPM is per se legal, manufacturers can compete for a retailer cartel’s patronage by selectively increasing MRP but not the price the retailers pay (price-to-retailer, or PTR). The retailer cartel can effectively collude on MRP (which serves as a focal point), allocate market shares among manufacturers based on the retail margins they receive, and, as a punishment, boycott manufacturers offering low margins. In such a setup, MRPM raises retailer profits at the expense of consumer welfare and contributes to the growth of manufacturers with relatively higher retailer margins and consumer prices.

I demonstrate the use of MRPM in raising a retailer cartel’s profits and the effective use of vertical punishments to enforce retailer margins. The empirical study is set in the Indian pharmaceutical industry, featuring a dominant retailer pharmacy cartel that enforces a minimum level of retailer margin and boycotts pharmaceutical manufacturers that breach the minimum. I exploit the mid-2013 price control regulation in India that expanded the set of pricecontrolled medicines threatening retailer profits due to: (a) a potential decline in the absolute price levels of newly price-controlled medicines; and (b) a likely reduction in the retailer margins on these medicines.

Using data collected by the retailer union, I document the selective increase in MRP—but not PTR—in a sample of essential medicines that entered the price control regime in India in 2013. I document the coordinated nature of the increase and the impact on manufacturers refusing to increase retailer margin by increasing MRP selectively. I also document the increase in retailer profits of brands with higher margins. I exploit an episode involving the boycott of sales of GSK’s best-selling medicine brand of amoxicillin in India, Augmentin, following GSK’s refusal to pledge a 30 percent margin on pricecontrolled medicines. GSK, the dominant manufacturer in the market with nearly 25 percent market share in 2011, lost almost 10 percent market share in six months, which was allocated to other producers offering higher margins.

The article contributes to the empirical literature on the facilitating role RPM plays in sustaining cartels. The presence of MRPM allows retailers to effectively collude on MRP, resulting in the decline of market share for lower-margin medicines. While the Indian case study is a striking example of the use of MRPM, in other jurisdictions, such as Switzerland, MRPM is replaced by recommended resale prices to achieve the same effect.

Continue reading the full text of this article and citations in PDF format.

The author thanks the AIOCD for sharing the data and Margaret Levenstein, Ted Rosenbaum (editor), Valerie Suslow, and participants at the annual conference at Mannheim Center for Competition and Innovation for valuable comments. The author also thanks Michael Presley for his excellent research assistance.

    Authors